Pampa Energia: The Potential Of Argentina's Energy Sector Leader |
Pampa Energía, a leading electricity producer in Argentina, holds a 15% market share and is highly diversified within the energy sector. The company operates in electric power generation, high-voltage power transmission, liquefied gas transportation, and has recently expanded into oil and gas extraction. Government measures under Alberto Fernández negatively impacted the energy sector, but conditions improved significantly during Milei's presidency. |
seekingalpha.com |
2025-05-13 13:45:18 |
Czytaj oryginał (ang.) |
Pampa Energía Announces First Quarter 2025 Results |
BUENOS AIRES, ARGENTINA / ACCESS Newswire / May 12, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP), an independent company with active participation in Argentine oil, gas and electricity, announces the results for the quarter ended on March 31, 2025. |
accessnewswire.com |
2025-05-12 22:10:00 |
Czytaj oryginał (ang.) |
5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio |
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like PCB, GIII, ROCK, PFE and PAM hold promise. |
zacks.com |
2025-05-09 13:15:42 |
Czytaj oryginał (ang.) |
Are Investors Undervaluing Pampa Energia (PAM) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-04-29 14:45:47 |
Czytaj oryginał (ang.) |
Addex Reports Full Year 2024 Financial Results and Provides Corporate Update |
Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for development in substance use disorders Addex selected independent GABAB PAM drug candidate for development in chronic cough Repositioned our phase 2 mGlu5 NAM asset, dipraglurant in brain injury recovery Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 25, 2025 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its full-year 2024 financial results for the period ended December 31, 2024 and provided a corporate update. |
globenewswire.com |
2025-04-25 05:00:00 |
Czytaj oryginał (ang.) |
3 Utility Stocks Set to Deliver 20%+ Returns in 2025 |
Utility stocks have long been a favorite for investors who are looking for stability and consistent returns in the current market. |
247wallst.com |
2025-04-24 15:24:35 |
Czytaj oryginał (ang.) |
All You Need to Know About Pampa (PAM) Rating Upgrade to Strong Buy |
Pampa (PAM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2025-04-22 17:00:38 |
Czytaj oryginał (ang.) |
New Strong Buy Stocks for April 22nd |
DPMLF, PAM, MTAL, HRTX and BALY have been added to the Zacks Rank #1 (Strong Buy) List on April 22, 2025. |
zacks.com |
2025-04-22 12:25:35 |
Czytaj oryginał (ang.) |
Best Value Stocks to Buy for April 22nd |
AES, PAM and DPMLF made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 22, 2025. |
zacks.com |
2025-04-22 09:10:32 |
Czytaj oryginał (ang.) |
Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies |
HOUSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Wound care patients across the PAM Health network of hospitals and outpatient clinics will now have access to an innovative new treatment to accelerate chronic wound healing. A multi-year exclusive agreement between PAM Health and Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial-stage medical device company at the forefront of biodynamic therapies, means Nuo's Aurix System will serve as the sole platelet-rich plasma (PRP) wound care therapy across all of PAM Health's long-term acute care hospitals, inpatient rehabilitation hospitals, and outpatient and wound care clinics. |
globenewswire.com |
2025-04-17 13:00:00 |
Czytaj oryginał (ang.) |
Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149 |
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that following the previously announced termination of development of ADX71149 (JNJ-40411813) in epilepsy, its partner Janssen Pharmaceuticals, Inc. (now known as J&J Innovative Medicine) has return all development and commercialization rights to ADX71149 (JNJ-40411813) and the partnership between the two companies has been terminated. |
globenewswire.com |
2025-04-17 05:00:00 |
Czytaj oryginał (ang.) |
Pampa Energia Informs that it has Filed its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024 |
BUENOS AIRES, AR / ACCESS Newswire / April 16, 2025 / Pampa Energía S.A. (NYSE: PAM)(Buenos Aires Stock Exchange:PAMP) (‘Pampa' or the ‘Company'), one of the leading energy companies in Argentina, with participation in the oil and gas and electricity value chain, announces that on April 16, 2025 it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the ‘2024 Annual Report') before the U.S. Securities and Exchange Commission (the ‘SEC'). |
accessnewswire.com |
2025-04-16 16:30:00 |
Czytaj oryginał (ang.) |
5 Bargain Picks With Low Price-to-Sales Ratios & High Upside Potential |
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, PCB, ROCK, PRAA and PAM hold promise. |
zacks.com |
2025-04-16 12:35:38 |
Czytaj oryginał (ang.) |
Pampa Energia: Strategic Infrastructure With Latent Upside |
Pampa Energía, Argentina's leading energy firm, shows strong growth in electricity generation and gas production, with significant investments in Vaca Muerta and a new wind power project. Despite a 57% stock rally, Pampa remains undervalued with P/E FWD at 8.57x and EV/EBITDA FWD at 4.68x, indicating a repricing opportunity. Financial health is robust, with net debt at 0.6x EBITDA and a cash position of $1,670 MM, positioning it among the least leveraged utilities. |
seekingalpha.com |
2025-04-15 10:56:09 |
Czytaj oryginał (ang.) |
Here's Why You Should Add Pampa Energia Stock to Your Portfolio Now |
PAM makes a strong case for investment, given its growth prospects, strong ROE, better debt management and focus on clean power generation. |
zacks.com |
2025-04-07 12:45:32 |
Czytaj oryginał (ang.) |
Is Pampa Energia (PAM) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2025-04-04 14:46:38 |
Czytaj oryginał (ang.) |
Marvell to Demonstrate Industry's First 400G/lane PAM4 Electrical-to-Optical Link Technology at OFC 2025 |
Marvell ® 400G Technology is an Industry Breakthrough Enabling a New Generation of PAM4 Network Connectivity SANTA CLARA, Calif. , March 31, 2025 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, will demonstrate the industry's first 400G/lane technology with complete electrical to optical link operating at 224 Gbaud at OFC 2025 taking place March 30-April 3, 2025 in San Francisco, CA. |
prnewswire.com |
2025-03-31 13:00:00 |
Czytaj oryginał (ang.) |
Stock Picks From Seeking Alpha's February 2025 New Analysts |
In February, twenty-three new analysts joined Seeking Alpha, offering diverse stock picks and insights, from biotech to automotive and energy sectors. Analysts provided ratings from Strong Sell to Strong Buy, with detailed justifications based on market trends, company fundamentals, and sector-specific challenges. Key investment theses include bearish views on German automotive and LNG sectors, while bullish on biotech, fintech, and energy companies. |
seekingalpha.com |
2025-03-06 17:30:31 |
Czytaj oryginał (ang.) |
Pampa Energia S.A. (PAM) Q4 2024 Earnings Call Transcript |
Pampa Energia S.A. (NYSE:PAM ) Q4 2024 Earnings Conference Call March 6, 2025 10:00 AM ET Company Participants Raquel Cardasz - Investor Relations Lida Wang - Investor Relations and Sustainability Officer Gustavo Mariani - Executive Vice President and Chief Executive Officer Adolfo Zuberbuhler - Executive director of finance (CFO) Horacio Turri - EVP and Executive Director of Exploration and Production Marina Mertens - Latin Securities Guido Bizzozero - Allaria Ledesma Bruno Montanari - Morgan Stanley Ignacio Sniechowski - IEB Gustavo Faria - Bank of America Claudia Rivera - Santander Florencia Torres - MetLife Tom Devine - Beekman Place Advisors Conference Call Participants Raquel Cardasz [Abrupt Start] Results video conference. |
seekingalpha.com |
2025-03-06 16:51:12 |
Czytaj oryginał (ang.) |
Pampa Energia: Attractive Valuation Despite Recent Gains |
Pampa Energia is Argentina's largest private energy conglomerate with a diversified portfolio in LNG, electric power, and petrochemical products, holding a strong market position. The company has solid fundamentals, including decreasing net debt, strong liquidity, and growing sales in both Power and Oil & Gas segments. Pampa's valuation remains attractive despite recent gains, trading at significant discounts compared to industry averages, with a target price suggesting further upside potential. |
seekingalpha.com |
2025-02-13 09:03:32 |
Czytaj oryginał (ang.) |
Marvell Unveils Industry's First 3nm 1.6 Tbps PAM4 Interconnect Platform to Scale Accelerated Infrastructure |
New Ara PAM4 DSP Reduces Optical Module Power by 20%, Enabling Mass Adoption of 200 Gbps per Lane and 1.6 Tbps Network Infrastructure to Meet Rising AI Bandwidth Demands SANTA CLARA, Calif. , Dec. 3, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), a leader in data infrastructure semiconductor solutions, today introduced Marvell® Ara, the industry's first 3nm 1.6 Tbps PAM4 interconnects platform featuring 200 Gbps electrical and optical interfaces. |
prnewswire.com |
2024-12-03 11:00:00 |
Czytaj oryginał (ang.) |
Top 4 Utilities Stocks That May Keep You Up At Night This Quarter |
As of Nov. 15, 2024, four stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. |
benzinga.com |
2024-11-15 09:11:56 |
Czytaj oryginał (ang.) |
Pampa Energia S.A. (PAM) Q3 2024 Earnings Call Transcript |
Pampa Energia S.A. (NYSE:PAM ) Q3 2024 Earnings Conference Call November 7, 2024 10:00 AM ET Company Participants Raquel Cardasz - Investor Relations Lida Wang - Investor Relations and Sustainability Officer Gustavo Mariani - Executive Vice president and Chief Executive Officer Nicolas Mindlin - Chief Financial Officer Horacio Jorge Tomas Turri - Head of E&P Conference Call Participants Bruno Montanari - Morgan Stanley Alejandro Demichelis - Jefferies Marina Mertens - Latine Securities Daniel Guardiola - BTG Ignacio Sniechowski - IEB Gustavo Faria - Bank of America Matías Cattaruzzi - AdCap Raquel Cardasz Good morning everyone and thank you for waiting. |
seekingalpha.com |
2024-11-10 04:36:06 |
Czytaj oryginał (ang.) |
5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up |
We have screened value stocks NOMD, LOCO, KBH, COLB and PAM based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential. |
zacks.com |
2024-11-04 11:06:10 |
Czytaj oryginał (ang.) |
Should Value Investors Buy Pampa Energia (PAM) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-11-01 12:46:15 |
Czytaj oryginał (ang.) |
Pampa Energia (PAM) Is Up 3.03% in One Week: What You Should Know |
Does Pampa Energia (PAM) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2024-10-18 17:00:32 |
Czytaj oryginał (ang.) |
Here's Why You Should Add Pampa Energia Stock to Your Portfolio Now |
PAM makes a strong case for investment, given its growth prospects, strong ROE, debt management and focus on clean power generation. |
zacks.com |
2024-10-18 13:55:29 |
Czytaj oryginał (ang.) |
Pick These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios |
We have screened bargain stocks PAM, NOMD, KBH, COLB and SLGN based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential. |
zacks.com |
2024-10-18 12:20:25 |
Czytaj oryginał (ang.) |
Discover Profitable Opportunities With 5 Low Price-to-Sales Stocks |
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, BTU, KBH, PAM and MPB hold promise. |
zacks.com |
2024-10-18 11:36:12 |
Czytaj oryginał (ang.) |
Are Investors Undervaluing Pampa Energia (PAM) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-10-16 14:45:28 |
Czytaj oryginał (ang.) |
Badge and CyberArk Announce Partnership to Redefine Privacy in PAM and Secrets Management |
Partnership aims to help businesses eliminate vulnerable attack surfaces and provide a more streamlined user experience. SAN FRANCISCO, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Badge Inc. |
globenewswire.com |
2024-10-08 16:08:00 |
Czytaj oryginał (ang.) |
5 Value Stocks With Alluring EV-to-EBITDA Ratios to Snap Up |
We have screened value stocks KT, PAM, HPE, NOMD and HG based on the EV-to-EBITDA ratio, which offers a clearer picture of valuation and earnings potential. |
zacks.com |
2024-10-01 12:55:18 |
Czytaj oryginał (ang.) |
Best Momentum Stocks to Buy for September 30th |
PAM, STRL, and ATAT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 30, 2024. |
zacks.com |
2024-09-30 15:16:09 |
Czytaj oryginał (ang.) |
Is Pampa Energia (PAM) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-09-30 14:45:19 |
Czytaj oryginał (ang.) |
Buy These Top 5 Price-to-Sales Stocks for Better Investment Returns |
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, SON, HG, PAM and PFE hold promise. |
zacks.com |
2024-09-30 14:25:14 |
Czytaj oryginał (ang.) |
New Strong Buy Stocks for September 30th |
MRX, ANGO, OPRA, ATAT and PAM have been added to the Zacks Rank #1 (Strong Buy) List on September 30, 2024. |
zacks.com |
2024-09-30 12:05:22 |
Czytaj oryginał (ang.) |
Best Value Stocks to Buy for September 30th |
OPRA, PAM, and SIRI made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 30, 2024. |
zacks.com |
2024-09-30 09:25:43 |
Czytaj oryginał (ang.) |
Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update |
Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM for schizophrenia Indivior selected GABA B PAM drug candidate for development in substance use disorders Addex selected independent GABAB PAM drug candidate for development in chronic cough Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 30, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its half-year and second quarter financial results for the periods ended June 30, 2024, and provided a corporate update. |
globenewswire.com |
2024-09-30 05:00:00 |
Czytaj oryginał (ang.) |
New Strong Buy Stocks for September 24th |
CLCO, BCH, IDR, ALK and PAM have been added to the Zacks Rank #1 (Strong Buy) List on September 24, 2024. |
zacks.com |
2024-09-24 11:26:11 |
Czytaj oryginał (ang.) |
Best Value Stocks to Buy for September 24th |
PAM, MARUY and ALK made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 24, 2024. |
zacks.com |
2024-09-24 10:30:18 |
Czytaj oryginał (ang.) |